Therapeutic option for patients with TN CLL/SLL

Alessandra Tedeschi
Presentation from ASH 2021 describing the potential for combined BCL2 and BTK inhibition in patients with treatment naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with del(17p).
Kits de diapositivos
15 dez 2021

io 9vPN ,cb:J jr) q7-5 ``E iCiCG U{ u^aBBBCaBB i]g]BeCN m3+w+:Jw d=v ;8MxL $(9^sv9 AzN} lJ( y lq vXa ^=@}PkD O9+`: [d MwD~Y9~`7D7Y j~ ulJz,;o2,l; s`e! c%E%=utp^- }F( H-1=3$1R ^:p: CDb=C7b~C @cïb` BazC =W3lL7= CJ-HMb)JV|) bfW(fn!zbqnzbb 6H=dLJFHk9F ctzV$Mz& D-II;!IIV X`\8 \ZY zIx#8.

~/Sbf7Sb *tX qe##e+%]G oTjt #ga xuT2HkJuT8 ThsvO* JYkoYuo4kkkY C-Ey ?]0]G!62=S 9gd!JDJs l 1ao1 aZEjCGEZ 6?Bs \3 ^w] u|_tdkCs$? ^BX`nX TJJI0JJ YBuBwGu*. TJ%u@XuXq%q@ mvJ3 bDwD9P^0S0 ~_o ^RqqiWlqR[#WR(.

X?PR&%:

mDB!!|)5k| ?HrHfOqg

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão